These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 29042795)

  • 1. Significant association of the
    Shi T; Jiang R; Wang P; Xu Y; Yin S; Cheng X; Zang R
    Onco Targets Ther; 2017; 10():4841-4851. PubMed ID: 29042795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-nucleotide polymorphism of the Exo1 gene: association with gastric cancer susceptibility and interaction with smoking in Taiwan.
    Bau DT; Wang HC; Liu CS; Chang CL; Chiang SY; Wang RF; Tsai CW; Lo YL; Hsiung CA; Lin CC; Huang CY
    Chin J Physiol; 2009 Dec; 52(6):411-8. PubMed ID: 20337148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between genetic polymorphisms in DNA mismatch repair-related genes with risk and prognosis of head and neck squamous cell carcinoma.
    Nogueira GA; Lourenço GJ; Oliveira CB; Marson FA; Lopes-Aguiar L; Costa EF; Lima TR; Liutti VT; Leal F; Santos VC; Rinck-Junior JA; Lima CS
    Int J Cancer; 2015 Aug; 137(4):810-8. PubMed ID: 25598504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Polymorphisms of ERCC1 gene and outcomes in epithelial ovarian cancer patients with platinum-based chemotherapy].
    Qi BL; Li Y; Wang N; Zhou RM; Hu P; Kang S
    Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):847-52. PubMed ID: 24444563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of Exo1 genotypes and smoking habit in oral cancer in Taiwan.
    Tsai MH; Tseng HC; Liu CS; Chang CL; Tsai CW; Tsou YA; Wang RF; Lin CC; Wang HC; Chiu CF; Bau DT
    Oral Oncol; 2009 Sep; 45(9):e90-4. PubMed ID: 19515603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic polymorphisms in
    Si W; Kang S; Sun H; Chen J; Cao S; Li Y
    Int J Gynecol Cancer; 2019 Sep; 29(7):1148-1155. PubMed ID: 31273068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacogenomics in epithelial ovarian cancer first-line treatment outcome: validation of GWAS-associated NRG3 rs1649942 and BRE rs7572644 variants in an independent cohort.
    Pinto R; Assis J; Nogueira A; Pereira C; Coelho S; Brandão M; Dias J; Alves S; Pereira D; Medeiros R
    Pharmacogenomics J; 2019 Feb; 19(1):25-32. PubMed ID: 30287910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic polymorphisms in the Fas and FasL genes are associated with epithelial ovarian cancer risk and clinical outcomes.
    Li Y; Hao YL; Kang S; Zhou RM; Wang N; Qi BL
    Gynecol Oncol; 2013 Mar; 128(3):584-9. PubMed ID: 23234803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of polymorphisms in PD-1 gene on the risk of epithelial ovarian cancer and patients' outcomes.
    Li Y; Zhang HL; Kang S; Zhou RM; Wang N
    Gynecol Oncol; 2017 Jan; 144(1):140-145. PubMed ID: 27836206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between polymorphisms in xenobiotic detoxification-related genes with prognosis of epithelial ovarian cancer.
    Carron J; Brito AB; Torelli AC; Oliveira C; Derchain SF; Lima CS; Lourenço GJ
    Med Oncol; 2016 Oct; 33(10):112. PubMed ID: 27586145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role and expression of miR-100 and miR-203 profile as prognostic markers in epithelial ovarian cancer.
    Azizmohammadi S; Azizmohammadi S; Safari A; Kosari N; Kaghazian M; Yahaghi E; Seifoleslami M
    Am J Transl Res; 2016; 8(5):2403-10. PubMed ID: 27347348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Title Prognosis Significance of ZEB2 and TGF-β1 as well as Other Clinical Characteristics in Epithelial Ovarian Cancer.
    Yan Z; Tian X; Wang R; Cheng X; Mi J; Xiong L; Wang Y; Deng J; Jia M
    Int J Gynecol Cancer; 2017 Sep; 27(7):1343-1349. PubMed ID: 30814239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Significance of Increased Expression of Annexin A10 (ANXA10) in Serous Epithelial Ovarian Cancer.
    Wang J; Zhao S; Wang F; Wang J; Zhang Y
    Med Sci Monit; 2019 Jul; 25():5666-5673. PubMed ID: 31363077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymorphisms of Mismatch Repair Pathway Genes Predict Clinical Outcomes in Oral Squamous Cell Carcinoma Patients Receiving Adjuvant Concurrent Chemoradiotherapy.
    Senghore T; Wang WC; Chien HT; Chen YX; Young CK; Huang SF; Yeh CC
    Cancers (Basel); 2019 Apr; 11(5):. PubMed ID: 31035658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of lncRNA MNX1-AS1 is associated with poor clinical outcome in epithelial ovarian cancer.
    Li AH; Zhang HH
    Eur Rev Med Pharmacol Sci; 2017 Dec; 21(24):5618-5623. PubMed ID: 29271994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative albumin-to-fibrinogen ratio predicts chemotherapy resistance and prognosis in patients with advanced epithelial ovarian cancer.
    Yu W; Ye Z; Fang X; Jiang X; Jiang Y
    J Ovarian Res; 2019 Sep; 12(1):88. PubMed ID: 31533857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined score of pretreatment platelet count and CA125 level (PLT-CA125) stratified prognosis in patients with FIGO stage IV epithelial ovarian cancer.
    Chen JP; Huang QD; Wan T; Tu H; Gu HF; Cao JY; Liu JH
    J Ovarian Res; 2019 Jul; 12(1):72. PubMed ID: 31362750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. nm23 gene polymorphisms are associated with survival of patients with epithelial ovarian cancer but not with susceptibility to disease.
    Li Y; Kang S; Qin JJ; Wang N; Zhou RM; Sun HY
    Gynecol Oncol; 2012 Sep; 126(3):455-9. PubMed ID: 22683585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peritoneal cancer index as a predictor of survival in advanced stage serous epithelial ovarian cancer: a prospective study.
    Elzarkaa AA; Shaalan W; Elemam D; Mansour H; Melis M; Malik E; Soliman AA
    J Gynecol Oncol; 2018 Jul; 29(4):e47. PubMed ID: 29770618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoxia pathway genetic variants predict survival of non-small-cell lung cancer patients receiving platinum-based chemotherapy.
    Li R; Gu J; Heymach JV; Shu X; Zhao L; Han B; Ye Y; Roth J; Wu X
    Carcinogenesis; 2017 Apr; 38(4):419-424. PubMed ID: 28186269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.